Our novel Chimeric Antigen Receptor (CAR) technology platform consists of several key services including CAR construction, pseudoviral particles production and stable transduction, meanwhile we also offer a series of high quality functional analysis, such as the genomic integration test, CAR expression test, cytokine release test, proliferation test and cytotoxicity test.